Allspring Global Investments’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Allspring Global Investments's CNMD Position: Q1 2026 in Review
Allspring Global Investments increased its CONMED (CNMD) stake by 40% in Q1 2026, buying an estimated $6.77M and bringing the position to 582,733 shares worth $20.7M. The position accounts for 0.03% of the portfolio, ranked #520.
Allspring Global Investments first reported a position in CNMD in Q4 2021 and has held it in 18 quarters since. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Allspring Global Investments held 582,733 shares of CONMED worth $20.7M as of Q1 2026.
- Allspring Global Investments bought 166,301 CONMED shares in Q1 2026, an estimated $6.77M.
- CONMED made up 0.03% of Allspring Global Investments's portfolio in Q1 2026, its #520 holding.
- Allspring Global Investments first reported a position in CONMED in Q4 2021 and has held it in 18 quarters since.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.